You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

271 Results
Document
New
Jul 2025
Document
New
Jul 2025
Regimen
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Sacituzumab Govitecan - Unresectable Locally Advanced or Metastatic Triple Negative Breast Cancer
New Drug Funding Program
    Sacituzumab Govitecan - HR-positive HER2-negative Unresectable Locally Advanced or Metastatic Breast Cancer
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
sacituzumab govitecan
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jul 2025
Drug
Other Name(s): Kadcyla®
Quick Link(s): Drug Monograph, Patient Info Sheet
Aug 2023
Drug
Other Name(s): Trodelvy®
Quick Link(s): Drug Monograph, Patient Info Sheet
Jul 2025
Guidelines and Advice
Status: Current
Updated
Aug 2025

Pages